Yasuko Mori

6.7k total citations
184 papers, 4.4k citations indexed

About

Yasuko Mori is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, Yasuko Mori has authored 184 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Epidemiology, 53 papers in Oncology and 42 papers in Infectious Diseases. Recurrent topics in Yasuko Mori's work include Herpesvirus Infections and Treatments (117 papers), Cytomegalovirus and herpesvirus research (93 papers) and Viral-associated cancers and disorders (49 papers). Yasuko Mori is often cited by papers focused on Herpesvirus Infections and Treatments (117 papers), Cytomegalovirus and herpesvirus research (93 papers) and Viral-associated cancers and disorders (49 papers). Yasuko Mori collaborates with scholars based in Japan, Indonesia and United States. Yasuko Mori's co-authors include Koichi Yamanishi, Huamin Tang, Tomohiko Sadaoka, Akiko Kawabata, Yasuyuki Gomi, Michiaki Takahashi, Shigefumi Okamoto, Yasuo Uchiyama, Mitsuhiro Nishimura and Hironori Yoshii and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yasuko Mori

178 papers receiving 4.3k citations

Peers

Countries citing papers authored by Yasuko Mori

Since Specialization

Citations

This map shows the geographic impact of Yasuko Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuko Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuko Mori more than expected).

Fields of papers citing papers by Yasuko Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuko Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuko Mori. The network helps show where Yasuko Mori may publish in the future.

Co-authorship network of co-authors of Yasuko Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuko Mori. A scholar is included among the top collaborators of Yasuko Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuko Mori. Yasuko Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java, Indonesia 2023 ·PeerJ ·(unknown), Laura Navika Yamani, Juniastuti Juniastuti, Maria Inge Lusida, Yasuko Mori	2
2	Growth, Pathogenesis, and Serological Characteristics of the Japanese Encephalitis Virus Genotype IV Recent Strain 19CxBa-83-Cv 2023 ·Viruses ·Shigeru Tajima, Takahiro Maeki, Eri Nakayama, Astri Nur Faizah, Daisuke Kobayashi, Haruhiko Isawa, Yoshihide Maekawa, (unknown), Kris Cahyo Mulyatno, (unknown), Yasuko Mori, Kyoko Sawabe, Hideki Ebihara, Chang‐Kweng Lim	2
3	Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination 2022 ·The Journal of Infectious Diseases ·(unknown), Koichi Furukawa, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sachiko Nakamura, Mitsuhiro Nishimura, Jun Arii, Tatsunori Kiriu, Masatsugu Yamamoto, Tatsuya Nagano, Yoshihiro Nishimura, Yasuko Mori	4
4	Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination 2022 ·Vaccines ·Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, (unknown), Hironori Sakai, (unknown), Akihito Kitao, (unknown), Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Mitsuhiro Ito, (unknown), Yoshinori Imamura, Naomi Kiyota, Hiroshi Matsuoka, Yasuko Mori, Hironobu Minami	3
5	Longitudinal changes in cell‐mediated immunity after varicella‐zoster virus skin test in the general population; Shozu Herpes Zoster Study: SHEZ study 2022 ·Journal of Medical Virology ·(unknown), Hironori Imano, Yasuko Mori, Hideo Asada, Koichi Yamanishi, Yoshinobu Okuno, Hiroyasu Iso	2
6	Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan 2021 ·Open Forum Infectious Diseases ·Koichi Furukawa, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sachiko Nakamura, Mitsuhiro Nishimura, Jun Arii, Tatsunori Kiriu, Masatsugu Yamamoto, Tatsuya Nagano, Yoshihiro Nishimura, Yasuko Mori	14
7	Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer 2021 ·Journal of Infection and Chemotherapy ·Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, (unknown), Hironori Sakai, (unknown), (unknown), Shinya Ohata, Yoshiaki Nagatani, (unknown), Akihito Kitao, (unknown), Yoshinori Imamura, Naomi Kiyota, Kenichi Harada, Yugo Tanaka, Yasuko Mori, Hironobu Minami	12
8	Massive surge of mRNA expression of clonal B-cell receptor in patients with COVID-19 2021 ·Heliyon ·Yohei Funakoshi, Goh Ohji, Kimikazu Yakushijin, (unknown), (unknown), Jun Saegusa, (unknown), (unknown), Eriko Fukuda, Takaji Matsutani, Yasuko Mori, Kentaro Iwata, Hironobu Minami	4
9	Bone marrow-derived mesenchymal stem cells attenuate pulmonary inflammation and lung damage caused by highly pathogenic avian influenza A/H5N1 virus in BALB/c mice 2020 ·BMC Infectious Diseases ·(unknown), Muhammad Amin, Fedik Abdul Rantam, (unknown), (unknown), (unknown), (unknown), Laksmi Wulandari, (unknown), (unknown), Gatot Soegiarto, Yohko K. Shimizu, Yasuko Mori, Kazufumi Shimizu	15
10	Entry of betaherpesviruses 2019 ·Advances in virus research ·Mitsuhiro Nishimura, Yasuko Mori	18
11	Vaccine Development for Varicella-Zoster Virus 2018 ·Advances in experimental medicine and biology ·Tomohiko Sadaoka, Yasuko Mori	12
12	Cytoplasmic tail domain of glycoprotein B is essential for HHV-6 infection 2016 ·Virology ·(unknown), Chyntia Olivia Maurine Jasirwan, (unknown), (unknown), Bochao Wang, Yuuki Hata, (unknown), Akiko Kawabata, Huamin Tang, Yasuko Mori	4
13	Characterization of the human herpesvirus 6A U23 gene 2013 ·Virology ·(unknown), (unknown), Huamin Tang, Tomohiko Sadaoka, Akiko Kawabata, Chyntia Olivia Maurine Jasirwan, Yasuko Mori	8
14	Novel monoclonal antibodies for identification of multicentric Castleman's disease; Kaposi's sarcoma-associated herpesvirus-encoded vMIP-I and vMIP-II 2012 ·Virology ·Kazushi Nakano, Harutaka Katano, Kenjiro Tadagaki, Yuko Sato, (unknown), Yasuko Mori, Koichi Yamanishi, Keiji Ueda	2
15	Comparison of the Cross-Reactive Anti-Influenza Neutralizing Activity of Polymeric and Monomeric IgA Monoclonal Antibodies 2012 ·Viral Immunology ·Takeshi Tanimoto, (unknown), Nobuyuki Takenaka, Shinichi Tamura, Yoshinobu Okuno, Yasuko Mori, Koichi Yamanishi, Shigefumi Okamoto	6
16	Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster 2012 ·Epidemiology and Infection ·Yoshinobu Okuno, (unknown), Yoshifumi Miyazaki, (unknown), (unknown), (unknown), (unknown), (unknown), Kazuhiro Maeda, Tetsuya Ishikawa, Yasuko Mori, Hideo Asada, Hiroyasu Iso, K Yamanishi	25
17	Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains 2012 ·Antiviral Research ·Hiroshi Yamada, Eiko Moriishi, (unknown), Nobuyuki Takenaka, Yasuko Mori, Koichi Yamanishi, Shigefumi Okamoto	12
18	Recent topics related to human herpesvirus 6 cell tropism 2009 ·Cellular Microbiology ·Yasuko Mori	54
19	Influenza hemagglutinin vaccine with poly(γ-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity 2007 ·Vaccine ·Shigefumi Okamoto, Hironori Yoshii, Takami Akagi, Mitsuru Akashi, Toyokazu Ishikawa, Yoshinobu Okuno, Michiaki Takahashi, Koichi Yamanishi, Yasuko Mori	36
20	Comparison of the Complete DNA Sequences of the Oka Varicella Vaccine and Its Parental Virus 2002 ·Journal of Virology ·Yasuyuki Gomi, (unknown), Yasuko Mori, Kazuhiro Nagaike, Michiaki Takahashi, Koichi Yamanishi	144

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact